Approximately 10–15 percent of breast cancer cases do not respond to treatment with hormone therapy, which means that they are more aggressive and often recur. An international research team led by researchers at Lund University in Sweden has uncovered a way to treat these aggressive tumors through manipulation of the connective tissue cells of a tumor. The researchers are now developing a new drug that transforms aggressive breast cancer so that it becomes responsive to standard hormone therapy.